Table 1.

Characteristics of the 38 AML patients at diagnosis

Patients, n	38
Male/female, n	22/16
Age at diagnosis, years	45 (15–82)
WBC at diagnosis, ×109/L	29.7 (l.2–234)
Blasts at diagnosis by flow cytometry, %	63.5 (23–95)
Cytogenetic risk group
Favourable	6 (16)
Intermediate	22 (58)
Poor	3 (8)
Could not be analysed	7 (18)
FLT3-ITD mutation
Positive	10 (26.3)
Negative	26 (68.4)
Could not be analysed	2 (5.3)
NPM1 mutation
Positive	2 (5.3)
Negative	27 (81.6)
Could not be analysed	5 (13.1)

Data are presented as n (%) or median (range).